ClinConnect ClinConnect Logo
Search / Trial NCT05555069

The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers

Launched by NIKKI NOLLEN, PHD, MA · Sep 22, 2022

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how menthol-flavored e-cigarettes compare to tobacco-flavored e-cigarettes in helping adult menthol smokers switch from traditional cigarettes to e-cigarettes. The goal is to see which flavor makes it easier for smokers to make this change and reduce their smoking. If you are an adult (21 years or older) who smokes at least 5 menthol cigarettes a day and has been smoking menthols for at least 6 months, you may be eligible to participate.

Participants in the study will be provided with e-cigarettes and will be asked to use them instead of regular cigarettes. During the trial, you'll receive support and guidance, and you’ll be able to share your experiences. It’s important to note that you should not be using any other tobacco products or trying to quit smoking, and certain health conditions may disqualify you from joining. If you’re interested in switching to e-cigarettes and want to learn more about this study, it could be a great opportunity for you!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ≥ 21 years of age
  • Smoke ≥ 5 cigarettes per day (CPD)
  • Smoke menthol cigarettes for ≥ 6 months
  • Verified smoker (CO \>5ppm)
  • Functioning telephone
  • Interested in switching to E-cigarettes
  • Exclusion Criteria:
  • Interested in quitting smoking
  • Use of other tobacco products in past 30 days (i.e. cigarillos, cigars, hookah, smokeless tobacco, pipes)
  • E-cigarette use on ≥ 4 of the past 30 days
  • Uncontrolled hypertension: BP ≥ 180(systolic) or ≥ 105 (diastolic)
  • Use of smoking cessation pharmacotherapy in the month prior to enrollment
  • Pregnant, contemplating getting pregnant, or breastfeeding
  • Plans to move from Kansas City during the treatment and follow-up phase
  • Another household member enrolled in the study

About Nikki Nollen, Phd, Ma

Nikki Nollen, PhD, MA, is a distinguished clinical trial sponsor with extensive expertise in behavioral health and public health research. With a robust academic background and a commitment to advancing innovative therapeutic interventions, Dr. Nollen leads clinical studies aimed at improving patient outcomes through evidence-based practices. Her multidisciplinary approach integrates psychological principles with clinical methodologies, fostering collaboration among researchers, healthcare professionals, and community stakeholders. Dr. Nollen is dedicated to ensuring the ethical conduct of trials and the rigorous evaluation of new treatments, contributing significantly to the field of clinical research.

Locations

Kansas City, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Nicole Nollen, PhD

Principal Investigator

University of Kanas Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials